Kiniksa Pharmaceuticals International (KNSA) EBT (2017 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly EBT came in at $31.1 million in Q2 2026, up 36.14% YoY from $22.9 million in Q2 2025, and down 4.7% on a QoQ basis from $32.7 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) EBT (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 10 years of EBT data on file, last reported at $31.1 million in Q2 2026.
- Quarterly EBT rose 36.14% year-over-year to $31.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $114.3 million (up 701.09% YoY) and the FY2025 annual result came in at $88.9 million, up 345.82% from the prior year.
- EBT fell to $31.1 million in Q2 2026, from $32.7 million in the prior quarter.
- In the past five years, EBT ranged from a high of $90.9 million in Q4 2022 to a low of -$72.0 million in Q4 2023.
- A 5-year average of $6.7 million and a median of $532500.0 in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT tumbled 179.24% — and 2025, when it soared 892.93%.
- Tracing KNSA's EBT over 5 years: stood at $90.9 million in 2022, then plunged by 179.24% to -$72.0 million in 2023, then soared by 76.43% to -$17.0 million in 2024, then jumped by 237.05% to $23.3 million in 2025, then surged by 33.85% to $31.1 million in 2026.
- The last three EBT figures came in at $31.1 million (Q2 2026), $32.7 million (Q1 2026), and $23.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.05 Bn | 5.52 Bn | 220.03 Mn | 31.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.15 Mn |
| Mar 31, 2026 | 32.68 Mn |
| Dec 31, 2025 | 23.27 Mn |
| Sep 30, 2025 | 27.16 Mn |
| Jun 30, 2025 | 22.88 Mn |
| Mar 31, 2025 | 15.57 Mn |
| Dec 31, 2024 | -16.98 Mn |
| Sep 30, 2024 | -7.20 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | -14.28 Mn |
| Dec 31, 2023 | -72.03 Mn |
| Sep 30, 2023 | -8.50 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Mar 31, 2023 | -9.36 Mn |
| Dec 31, 2022 | 90.91 Mn |
| Sep 30, 2022 | 46.74 Mn |
| Jun 30, 2022 | -19.27 Mn |
| Mar 31, 2022 | -23.29 Mn |
| Dec 31, 2021 | -43.80 Mn |
| Sep 30, 2021 | -30.66 Mn |